PEPTIDE 1 – Ipamorelin
Ipamorelin is a growth hormone releasing peptide (GHRP) similar to GHRP2 and GHRP6 that was developed by Novo Nordisk. It is a pentapeptide composed of 5 amino acids that causes a significant release of growth hormone from the anterior pituitary gland, and has the dual action of also suppressing Somatostatin, a peptide hormone that inhibits the release of growth hormone. The benefits of using Ipamorelin are increased fat loss, maintenance of lean muscle tissue, rejuvenation and strengthening of joints, connective tissue and bone mass, as well as other anti-aging benefits associated with GH treatment such as improved skin tone and hair quality.
PEPTIDE 2 – Modified GRF (1-29)
Modified GRF 1-29 or Mod GRF 1-29 refers to a 29 amino acid peptide analog of GHRH and a modified variant of the shortest completely functional fragment GRF 1-29 also known as Sermorelin.
Mod GRF 1-29 basically increase the production of growth hormones and releases them by binding onto the growth hormone receptors found in the anterior pituitary gland’s cells.
GRF 1-29 is the part of the 44 amino acid GHRH that is actually biologically active. It has a half-life of under 10 minutes. The Mod GRF 1-29 replacement of GRF 1-29′s 2nd, 8th, 15th and 27th amino acids brings about Mod GRF 1-29, which has a half-life of at least half an hour.